Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

36 results
  1. ... phase I-II randomized clinical studies have examined isoflavones and soy product for bioavailability , safety, and effectiveness in prostate cancer prevention or treatment.[ ...
  2. ... on the health effects of soy and its isoflavones on the following: menopausal symptoms, bone health, cancers, cardiovascular diseases, kidney diseases and cognitive function, as well as safety issues and drug interactions. In addition, this report ...
  3. ... some confusion about the mechanisms of action and safety of these plant-based estrogens. Isoflavones have properties that can cause estrogen-like effects ...
  4. ... JH, et al. A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women. Age Ageing. ...
  5. ... to women that there is some evidence that isoflavones or black cohosh may relieve vasomotor symptoms. However, explain that: multiple preparations are available and their safety is uncertain different preparations may vary interactions with ...
  6. ... H, Brandao LC, D'Almeida V, et al. Isoflavones decrease insomnia in postmenopause. Menopause. 2011 Feb; 18 (2):178–84. [ PubMed : 20729765 ] 128. Zick SM, Wright BD, Sen A, et al. Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary ...
  7. ... large trials examining vitamin E, small trials of isoflavones, and ... neither were safety signals apparent. However, given the large numbers of ...
  8. ... IU, Forman JD, Sarkar FH, et al. Soy isoflavones in conjunction with radiation therapy in patients with ... H, Tsukamoto T, et al. Efficacy and safety of dutasteride on prostate cancer risk reduction in ...
  9. ... W. W., Kim H. The role of soy isoflavones in menopausal health: Report of the North American ... T., Bao W., Ninan P. T. Efficacy and safety of desvenlafaxine 50 mg/d in a randomized, ...
  10. ... vasomotor symptoms across estrogen doses is rated moderate. Isoflavones Compared With Placebo There were pairwise comparisons of ... estrogen dose is rated moderate. Estrogen Compared With Isoflavones A single trial (poor quality) compared standard dose ...
first · previous · 1 · 2 · 3 · 4 · next · last